Weidner W - Search Results

1

Diagnostic value of magnetic resonance imaging in Peyronie's disease--a comparison both with palpation and ultrasound in the evaluation of plaque formation.

Hauck EW, Hackstein N, Vosshenrich R, Diemer T, Schmelz HU, Bschleipfer T, Schroeder-Printzen I, Weidner W. Hauck EW, et al. Among authors: weidner w. Eur Urol. 2003 Mar;43(3):293-9; discussion 299-300. doi: 10.1016/s0302-2838(03)00003-4. Eur Urol. 2003. PMID: 12600434

2

Alpha-1-antitrypsin levels and genetic variation of the alpha-1-antitrypsin gene in Peyronie's disease.

Hauck EW, Hauptmann A, Haag SM, Bohnert A, Weidner W, Bein G, Hackstein H. Hauck EW, et al. Among authors: weidner w. Eur Urol. 2004 Nov;46(5):623-8; discussion 628. doi: 10.1016/j.eururo.2004.04.028. Eur Urol. 2004. PMID: 15474273

3

Evaluation of penile perfusion by color-coded duplex sonography in the management of erectile dysfunction.

Altinkilic B, Hauck EW, Weidner W. Altinkilic B, et al. Among authors: weidner w. World J Urol. 2004 Nov;22(5):361-4. doi: 10.1007/s00345-004-0423-y. Epub 2004 Jul 20. World J Urol. 2004. PMID: 15672279 Review.

4

Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: a prospective, placebo-controlled, randomized study.

Weidner W, Hauck EW, Schnitker J; Peyronie's Disease Study Group of Andrological Group of German Urologists. Weidner W, et al. Eur Urol. 2005 Apr;47(4):530-5; discussion 535-6. doi: 10.1016/j.eururo.2004.12.022. Epub 2005 Jan 13. Eur Urol. 2005. PMID: 15774254 Clinical Trial.

5

A critical analysis of nonsurgical treatment of Peyronie's disease.

Hauck EW, Diemer T, Schmelz HU, Weidner W. Hauck EW, et al. Among authors: weidner w. Eur Urol. 2006 Jun;49(6):987-97. doi: 10.1016/j.eururo.2006.02.059. Epub 2006 Mar 20. Eur Urol. 2006. PMID: 16698449 Review.

6

Alterations in the transforming growth factor (TGF)-beta pathway as a potential factor in the pathogenesis of Peyronie's disease.

Haag SM, Hauck EW, Szardening-Kirchner C, Diemer T, Cha ES, Weidner W, Eickelberg O. Haag SM, et al. Among authors: weidner w. Eur Urol. 2007 Jan;51(1):255-61. doi: 10.1016/j.eururo.2006.05.002. Epub 2006 May 19. Eur Urol. 2007. PMID: 16782264

7

Investigation of the antifibrotic effect of IFN-gamma on fibroblasts in a cell culture model of Peyronie's disease.

Haag SM, Hauck EW, Eickelberg O, Szardening-Kirchner C, Diemer T, Weidner W. Haag SM, et al. Among authors: weidner w. Eur Urol. 2008 Feb;53(2):425-30. doi: 10.1016/j.eururo.2007.06.036. Epub 2007 Jun 27. Eur Urol. 2008. PMID: 17630104

8

Questionable efficacy of extracorporeal shock wave therapy for Peyronie's disease: results of a prospective approach.

Hauck EW, Hauptmann A, Bschleipfer T, Schmelz HU, Altinkilic BM, Weidner W. Hauck EW, et al. Among authors: weidner w. J Urol. 2004 Jan;171(1):296-9. doi: 10.1097/01.ju.0000099891.68488.4e. J Urol. 2004. PMID: 14665898

9

Extracorporeal shock wave therapy for Peyronie's disease: exploratory meta-analysis of clinical trials.

Hauck EW, Mueller UO, Bschleipfer T, Schmelz HU, Diemer T, Weidner W. Hauck EW, et al. Among authors: weidner w. J Urol. 2004 Feb;171(2 Pt 1):740-5. doi: 10.1097/01.ju.0000108060.30363.8d. J Urol. 2004. PMID: 14713800

10

Prospective analysis of single nucleotide polymorphisms of the transforming growth factor beta-1 gene in Peyronie's disease.

Hauck EW, Hauptmann A, Schmelz HU, Bein G, Weidner W, Hackstein H. Hauck EW, et al. Among authors: weidner w. J Urol. 2003 Jan;169(1):369-72. doi: 10.1016/S0022-5347(05)64129-8. J Urol. 2003. PMID: 12478192

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

625 results

Search Page

Filters